Moreover, in BC an enrichment of ILC2s in tumors compared to healthy tissue was observed, and IL-33 administration in 4T1 BC cell model accelerates tumor growth and the development of lung and liver metastases, which is associated with increased intratumoral infiltration of ILCs, MDSCs and Tregs (73, 74). This evidence concerns the gene IL33 and breast cancer.